Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

The Canadian Journal of Psychiatry(2023)10.1177/07067437231194385Source: DataRank Database

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial is a research paper published in The Canadian Journal of Psychiatry (2023). On theSindex it has a DataRank of 0.266. It has been cited 4 times, with 4 citing works in its 1-hop citation network.

N/A

0.266DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access4 citations · 4 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT03033732

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.95)OA: hybridTopics (60)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 91%Citation Network 9%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

0.0246

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 4 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 4 citers.

Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative outpatient clinic data
Drug and Alcohol Dependence20259 citations119 referencesContributes 0.019
Pharmacological Strategies to Decrease Long-Term Prescription Opioid Use: A Systematic Review
Journal of Clinical Medicine20242 citations115 referencesContributes 0.010
Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative study
medRxiv20240 citations93 referencesContributes 0.000
The effect of the physician-nurse-social worker linkage rehabilitation model on the psychological status of MMT patients
Heroin addiction and related clinical problems20240 citations24 referencesContributes 0.000

Authors (8)

Gabriel Bastien ORCID,Paxton Bach ORCID,JinCheol Choi ORCID,Bernard Le Foll ORCID,Ron Lim

Live enrichment

PubMed:37697811 PMC:PMC10874605 OpenAlex:https://openalex.org/W4386623736

Canadian Institutes of Health Research

Grant: CIS-144301, CIS-144302, CIS-144303, CIS-144304, SM

NIDA NIH HHS

Grant: R25 DA037756

Canadian Institutes of Health Research

Grant: unidentified

unidentified

FWCI

0.95

Citation Percentile

0.8%

Citation Trend

2024

2025

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1177/07067437231194385

publisherhttps://doi.org/10.1177/07067437231194385

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/07067437231194385

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/07067437231194385

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37697811

Fields of Study

Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPain Management and Opioid Use03 medical and health sciences0305 other medical scienceAdultFemaleMaleHumansAnalgesics, OpioidMethadoneOpiate Substitution TreatmentSelf ReportCanadaGender IdentityOpioid-Related DisordersBuprenorphine, Naloxone Drug CombinationAnxiety

MeSH Terms

Buprenorphine, Naloxone Drug CombinationAdultAnalgesics, OpioidAnxietyCanadaFemaleGender IdentityHumansMaleMethadoneOpioid-Related DisordersSelf ReportOpiate Substitution Treatment

Keywords

AnxietyMedicineBeck Anxiety InventoryConfidence intervalOpioidRandomized controlled trialOpioid use disorderOdds ratioBuprenorphineInternal medicinePsychiatryBeck Depression InventoryAnalgesicsMethadoneHumansAnxiety DisorderOpioid-related DisorderNaloxone Drug CombinationAdultMaleCanadaGender IdentityOpioid-Related DisordersAnalgesics, OpioidOpiate Substitution TreatmentFemaleSelf ReportBuprenorphine, Naloxone Drug CombinationRegular Articles

Sustainable Development Goals

SDG 0: Good health and well-being

sj-png-1-cpa-10.1177_07067437231194385 - Supplemental material for The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

10.25384/sage.24129319SAGE Journals

sj-pdf-2-cpa-10.1177_07067437231194385 - Supplemental material for The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

10.25384/sage.24129322SAGE Journals

sj-pdf-2-cpa-10.1177_07067437231194385 - Supplemental material for The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

10.25384/sage.24129322.v1SAGE Journals

sj-png-1-cpa-10.1177_07067437231194385 - Supplemental material for The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

10.25384/sage.24129319.v1SAGE Journals